<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Reported-in-House" dms-id="H7A456AC090F140629EEA064706CB17A6" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 2004 RH: Tyler’s Law</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2026-09-14</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">IB</distribution-code><calendar display="yes">Union Calendar No. 716</calendar><congress display="yes">119th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 2004</legis-num><associated-doc role="report" display="yes">[Report No. 119–817]</associated-doc><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250310">March 10, 2025</action-date><action-desc><sponsor name-id="L000582">Mr. Lieu</sponsor> (for himself, <cosponsor name-id="L000566">Mr. Latta</cosponsor>, <cosponsor name-id="K000400">Ms. Kamlager-Dove</cosponsor>, <cosponsor name-id="G000551">Mr. Grijalva</cosponsor>, <cosponsor name-id="C001120">Mr. Crenshaw</cosponsor>, <cosponsor name-id="B001306">Mr. Balderson</cosponsor>, <cosponsor name-id="C001133">Mr. Ciscomani</cosponsor>, <cosponsor name-id="V000129">Mr. Valadao</cosponsor>, <cosponsor name-id="L000599">Mr. Lawler</cosponsor>, <cosponsor name-id="D000629">Ms. Davids of Kansas</cosponsor>, <cosponsor name-id="N000147">Ms. Norton</cosponsor>, <cosponsor name-id="K000391">Mr. Krishnamoorthi</cosponsor>, <cosponsor name-id="C001127">Mrs. Cherfilus-McCormick</cosponsor>, <cosponsor name-id="B001300">Ms. Barragán</cosponsor>, <cosponsor name-id="V000131">Mr. Veasey</cosponsor>, <cosponsor name-id="T000468">Ms. Titus</cosponsor>, <cosponsor name-id="M001238">Ms. McBride</cosponsor>, <cosponsor name-id="D000624">Mrs. Dingell</cosponsor>, <cosponsor name-id="B001298">Mr. Bacon</cosponsor>, and <cosponsor name-id="P000608">Mr. Peters</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><action display="yes"><action-date date="20260914">September 14, 2026</action-date><action-desc>Additional sponsors: <cosponsor name-id="F000466">Mr. Fitzpatrick</cosponsor>, <cosponsor name-id="Y000067">Mr. Yakym</cosponsor>, <cosponsor name-id="G000583">Mr. Gottheimer</cosponsor>, <cosponsor name-id="L000601">Mr. Landsman</cosponsor>, <cosponsor name-id="N000193">Mr. Nunn of Iowa</cosponsor>, <cosponsor name-id="M001215">Mrs. Miller-Meeks</cosponsor>, <cosponsor name-id="C001119">Ms. Craig</cosponsor>, <cosponsor name-id="B001257">Mr. Bilirakis</cosponsor>, <cosponsor name-id="K000385">Ms. Kelly of Illinois</cosponsor>, <cosponsor name-id="M001205">Mrs. Miller of West Virginia</cosponsor>, <cosponsor name-id="K000397">Mrs. Kim</cosponsor>, <cosponsor name-id="O000172">Ms. Ocasio-Cortez</cosponsor>, <cosponsor name-id="D000594">Ms. De La Cruz</cosponsor>, <cosponsor name-id="T000469">Mr. Tonko</cosponsor>, <cosponsor name-id="E000300">Mr. Evans of Colorado</cosponsor>, <cosponsor name-id="W000814">Mr. Weber of Texas</cosponsor>, <cosponsor name-id="T000482">Mrs. Trahan</cosponsor>, <cosponsor name-id="S001216">Ms. Schrier</cosponsor>, <cosponsor name-id="M001227">Ms. McClellan</cosponsor>, <cosponsor name-id="S001145">Ms. Schakowsky</cosponsor>, <cosponsor name-id="R000599">Mr. Ruiz</cosponsor>, <cosponsor name-id="O000019">Mr. Obernolte</cosponsor>, <cosponsor name-id="S001200">Mr. Soto</cosponsor>, <cosponsor name-id="B001315">Ms. Budzinski</cosponsor>, <cosponsor name-id="B001327">Mr. Bresnahan</cosponsor>, <cosponsor name-id="D000631">Ms. Dean of Pennsylvania</cosponsor>, <cosponsor name-id="K000402">Mr. Kennedy of New York</cosponsor>, <cosponsor name-id="H001085">Ms. Houlahan</cosponsor>, <cosponsor name-id="S001201">Mr. Suozzi</cosponsor>, <cosponsor name-id="M001230">Mr. Mackenzie</cosponsor>, <cosponsor name-id="P000048">Mr. Pfluger</cosponsor>, <cosponsor name-id="P000614">Mr. Pappas</cosponsor>, <cosponsor name-id="W000797">Ms. Wasserman Schultz</cosponsor>, <cosponsor name-id="R000609">Mr. Rutherford</cosponsor>, <cosponsor name-id="F000478">Mr. Fry</cosponsor>, <cosponsor name-id="F000484">Mr. Fine</cosponsor>, <cosponsor name-id="M001216">Mr. Mills</cosponsor>, <cosponsor name-id="D000628">Mr. Dunn of Florida</cosponsor>, <cosponsor name-id="A000379">Mr. Alford</cosponsor>, <cosponsor name-id="V000136">Mr. Vasquez</cosponsor>, <cosponsor name-id="M001226">Mr. Menendez</cosponsor>, <cosponsor name-id="N000191">Mr. Neguse</cosponsor>, <cosponsor name-id="W000795">Mr. Wilson of South Carolina</cosponsor>, <cosponsor name-id="B001281">Mrs. Beatty</cosponsor>, <cosponsor name-id="M001204">Mr. Meuser</cosponsor>, and <cosponsor name-id="M001236">Mr. Moore of North Carolina</cosponsor></action-desc></action><action display="yes"><action-date date="20260914">September 14, 2026</action-date><action-desc>Committed to the Committee of the Whole House on the State of the Union and ordered to be printed</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, and for other purposes.<pagebreak></pagebreak></official-title></form><legis-body id="H68B1022A1999476AAC7016231DB40B30" style="OLC"><section id="H195F38C98DA742D093C950919AA4506B" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as <quote><short-title>Tyler’s Law</short-title></quote>.</text></section><section id="H0AD006A0D45C424196E3B36F6020E047"><enum>2.</enum><header>Testing for fentanyl in hospital emergency departments</header><subsection id="H8C98A3F87E3F47FD998591A216FC6BB5"><enum>(a)</enum><header>Study</header><text display-inline="yes-display-inline">Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services shall complete a study to determine—</text><paragraph id="HE7AC820ABDB949E49A6BC621DED2B7E2"><enum>(1)</enum><text>how frequently hospital emergency departments test for fentanyl (in addition to testing for other substances such as amphetamines, phencyclidine, cocaine, opiates, and marijuana) when a patient is experiencing an overdose;</text></paragraph><paragraph id="HC7701C66EC68478B8D80A6E996DF56CD"><enum>(2)</enum><text>the costs associated with such testing for fentanyl;</text></paragraph><paragraph id="H6D05ED3CCF094B059C59892B6EF3EF82"><enum>(3)</enum><text>the potential benefits and risks for patients receiving such testing for fentanyl; and</text></paragraph><paragraph id="H93678EF07A344F42A1449AF74DD1FB21"><enum>(4)</enum><text display-inline="yes-display-inline">how fentanyl testing in hospital emergency departments may impact the experience of the patient, including—</text><subparagraph id="H43BBB68B06D24B2D9C8508DF2557972D"><enum>(A)</enum><text>protections for the confidentiality and privacy of the patient’s personal health information; and</text></subparagraph><subparagraph id="H16F6D7ECC56F4BAB8B8990AB4F2329F6"><enum>(B)</enum><text>the patient-physician relationship.</text></subparagraph></paragraph></subsection><subsection id="H97FCBDF04CA9442089CC65918CE420B4"><enum>(b)</enum><header>Guidance</header><text>Not later than 6 months after completion of the study under subsection (a), based on the results of such study, the Secretary of Health and Human Services shall issue guidance on the following:</text><paragraph id="H5F291E94C51848F0B7546AA4B4136E58"><enum>(1)</enum><text>Whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose.</text></paragraph><paragraph id="H487C53C87E8049D48F21717530AB59FF"><enum>(2)</enum><text>How hospitals can ensure that clinicians in their hospital emergency departments are aware of which substances are being tested for in their routinely-administered drug tests, regardless of whether those tests screen for fentanyl.</text></paragraph><paragraph id="H0BECC3F3C6A2497B99B818EE8DE46993"><enum>(3)</enum><text display-inline="yes-display-inline">How the administration of fentanyl testing in hospital emergency departments may affect the future risk of overdose and general health outcomes.</text></paragraph></subsection><subsection id="H0A4C9C3DDCF241B38B429BEB70519608"><enum>(c)</enum><header>Definition</header><text>In this section, the term <term>hospital emergency department</term> means a hospital emergency department as such term is used in section 1867(a) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395dd">42 U.S.C. 1395dd(a)</external-xref>).</text></subsection></section></legis-body><endorsement display="yes"><action-date date="20260914">September 14, 2026</action-date><action-desc>Committed to the Committee of the Whole House on the State of the Union and ordered to be printed</action-desc></endorsement></bill> 

